Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 8.051 Q1 | 254 | 26 | 94 | 10565 | 1986 | 94 | 20.57 | 406.35 | |
2 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.242 Q4 | 50 | 11 | 63 | 2385 | 27 | 41 | 0.22 | 216.82 | |
3 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.706 Q1 | 82 | 14 | 45 | 2887 | 315 | 45 | 7.00 | 206.21 | |
4 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 3 | 11 | 596 | 1 | 11 | 0.14 | 198.67 | ||
5 | Pharmacology and Therapeutics | journal | 4.450 Q1 | 233 | 131 | 331 | 24955 | 4010 | 330 | 11.62 | 190.50 | |
6 | Medicinal Research Reviews | journal | 2.701 Q1 | 150 | 33 | 111 | 6234 | 1030 | 111 | 9.20 | 188.91 | |
7 | Report on carcinogens. Monograph on .. | book series | 0.111 | 2 | 4 | 5 | 716 | 1 | 5 | 0.00 | 179.00 | |
8 | Drug Resistance Updates | journal | 3.794 Q1 | 132 | 31 | 41 | 5374 | 454 | 41 | 12.10 | 173.35 | |
9 | Reviews of Physiology Biochemistry and Pharmacology | journal | 2.844 Q1 | 70 | 11 | 19 | 1872 | 114 | 13 | 4.64 | 170.18 | |
10 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.236 Q3 | 29 | 6 | 30 | 995 | 46 | 0 | 1.44 | 165.83 | |
11 | Advanced Drug Delivery Reviews | journal | 4.262 Q1 | 366 | 197 | 479 | 31881 | 7286 | 432 | 11.46 | 161.83 | |
12 | Advances in Molecular Toxicology | book series | 0.129 Q4 | 18 | 9 | 22 | 1428 | 7 | 0 | 0.33 | 158.67 | |
13 | Advances in Pharmacology | journal | 1.526 Q1 | 86 | 39 | 119 | 5476 | 463 | 0 | 3.76 | 140.41 | |
14 | Perspectives in Medicinal Chemistry | journal | 2.425 Q1 | 17 | 2 | 8 | 277 | 83 | 8 | 10.38 | 138.50 | |
15 | Drug Metabolism Reviews | journal | 1.129 Q1 | 108 | 33 | 98 | 4523 | 401 | 94 | 4.15 | 137.06 | |
16 | Journal of Receptor, Ligand and Channel Research | journal | 0.196 Q4 | 13 | 1 | 16 | 137 | 7 | 16 | 0.50 | 137.00 | |
17 | Nanotechnology, Science and Applications | journal | 1.048 Q1 | 35 | 4 | 12 | 548 | 106 | 12 | 8.83 | 137.00 | |
18 | Topics in Medicinal Chemistry | book series | 0.358 Q3 | 15 | 20 | 55 | 2711 | 41 | 51 | 0.75 | 135.55 | |
19 | Natural Product Reports | journal | 3.534 Q1 | 211 | 77 | 233 | 10320 | 2406 | 227 | 10.04 | 134.03 | |
20 | Current Medicinal Chemistry | journal | 1.085 Q2 | 202 | 276 | 956 | 36282 | 3493 | 901 | 3.39 | 131.46 | |
21 | Current Pharmaceutical Design | journal | 1.069 Q1 | 183 | 581 | 1906 | 75638 | 5822 | 1740 | 2.73 | 130.19 | |
22 | Cellular and Molecular Life Sciences | journal | 3.259 Q1 | 261 | 305 | 919 | 38436 | 5674 | 909 | 6.22 | 126.02 | |
23 | Annual Review of Pharmacology and Toxicology | journal | 8.284 Q1 | 224 | 31 | 87 | 3850 | 1380 | 85 | 13.47 | 124.19 | |
24 | Current Drug Metabolism | journal | 0.881 Q2 | 122 | 86 | 242 | 10388 | 738 | 223 | 2.77 | 120.79 | |
25 | Nano Today | journal | 6.225 Q1 | 175 | 52 | 194 | 6229 | 2138 | 130 | 11.38 | 119.79 | |
26 | RSC Drug Discovery Series | book series | 0.183 Q4 | 13 | 104 | 139 | 12446 | 44 | 127 | 0.32 | 119.67 | |
27 | Studies in Natural Products Chemistry | book series | 0.274 Q3 | 49 | 66 | 110 | 7763 | 119 | 14 | 1.17 | 117.62 | |
28 | Progress in Medicinal Chemistry | journal | 1.714 Q1 | 38 | 6 | 17 | 656 | 73 | 0 | 5.36 | 109.33 | |
29 | Current Drug Targets | journal | 1.172 Q1 | 119 | 241 | 469 | 26140 | 1431 | 426 | 2.58 | 108.46 | |
30 | Current Neuropharmacology | journal | 1.385 Q1 | 103 | 120 | 169 | 12931 | 723 | 150 | 3.15 | 107.76 | |
31 | Critical Reviews in Toxicology | journal | 1.809 Q1 | 129 | 44 | 127 | 4733 | 717 | 118 | 5.51 | 107.57 | |
32 | Expert Opinion on Therapeutic Targets | journal | 1.765 Q1 | 106 | 119 | 377 | 12656 | 1702 | 366 | 4.53 | 106.35 | |
33 | Current Topics in Medicinal Chemistry | journal | 0.879 Q2 | 133 | 294 | 694 | 31134 | 1958 | 611 | 2.62 | 105.90 | |
34 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 11 | 76 | 1147 | 143 | 63 | 1.25 | 104.27 | ||
35 | Milestones in Drug Therapy | book series | 0.100 Q4 | 6 | 15 | 45 | 1560 | 0 | 43 | 0.00 | 104.00 | |
36 | International Nano Letters | journal | 26 | 2 | 2 | 206 | 16 | 2 | 8.00 | 103.00 | ||
37 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.987 Q1 | 99 | 19 | 41 | 1932 | 274 | 41 | 6.22 | 101.68 | |
38 | Neurotherapeutics | journal | 2.283 Q1 | 136 | 80 | 225 | 7887 | 1273 | 211 | 5.65 | 98.59 | |
39 | Current Psychopharmacology | journal | 0.109 Q4 | 4 | 16 | 4 | 1576 | 1 | 3 | 0.25 | 98.50 | |
40 | Antibodies | journal | 0.341 Q3 | 42 | 21 | 71 | 2063 | 108 | 70 | 1.00 | 98.24 | |
41 | Handbook of Experimental Pharmacology | journal | 1.710 Q1 | 110 | 54 | 350 | 5252 | 1441 | 318 | 4.15 | 97.26 | |
42 | Current Molecular Pharmacology | journal | 1.090 Q1 | 49 | 37 | 73 | 3579 | 167 | 62 | 2.19 | 96.73 | |
43 | Vaccines | journal | 1.457 Q1 | 85 | 48 | 95 | 4565 | 385 | 92 | 4.08 | 95.10 | |
44 | Expert Opinion on Emerging Drugs | journal | 0.762 Q2 | 54 | 38 | 131 | 3609 | 377 | 127 | 3.21 | 94.97 | |
45 | Current Topics in Pharmacology | journal | 0.126 Q4 | 8 | 4 | 37 | 377 | 6 | 37 | 0.19 | 94.25 | |
46 | Mini-Reviews in Medicinal Chemistry | journal | 0.728 Q2 | 107 | 186 | 377 | 17338 | 1120 | 354 | 2.46 | 93.22 | |
47 | Expert Opinion on Drug Discovery | journal | 1.116 Q1 | 84 | 105 | 306 | 9743 | 1146 | 304 | 3.68 | 92.79 | |
48 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.929 Q1 | 150 | 175 | 558 | 16223 | 2651 | 551 | 4.50 | 92.70 | |
49 | Current Cancer Drug Targets | journal | 1.271 Q1 | 103 | 84 | 221 | 7769 | 816 | 205 | 2.78 | 92.49 | |
50 | Journal of Cardiovascular Development and Disease | journal | 32 | 33 | 37 | 3037 | 48 | 35 | 1.30 | 92.03 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®